Back to Insights

Case Study: GAIA AI Assistant for Live Commerce & Product Enablement

Case Studies, AI & GenAI: Yannis Boukas

How Galderma's GAIA AI Assistant powered live commerce and real-time product advice for Cetaphil & Benzac.

 

Client Profile

Galderma, a global dermatology leader with brands including Cetaphil and Benzac, partnered with Lingaro across APAC and JPAC to enhance social commerce and live commerce performance using AI.

 

Challenge

Galderma needed to accelerate live commerce sales, deliver consistent product knowledge across markets, and shorten onboarding time for sales associates. This work had to meet rising consumer expectations for instant, accurate answers in fast-growing social commerce channels.

 

Solution

Lingaro built GAIA, an AI powered assistant designed for TikTok livestreams and internal teams. The solution combines human centric UX, deep pharma domain expertise, and an adoption first approach to scale real time Q&A, unified product education, and rapid onboarding across the region.

 

Impact

GAIA was embedded in daily workflows and delivered measurable business outcomes, including:

  • +10% sales uplift during livestreams
  • 15× faster onboarding
  • 4.5/5 user satisfaction rating

 

 

Download Full Case Study

 

 

Yannis Boukas
Yannis Boukas Director of Learning Technology & Adoption

Driven to build productive and inclusive organizations where every employee can unlock their full potential, Yannis is armed with years of experience in driving complex transformative programs, ensuring business impact realization. His expertise spans business, technology, and learning across multiple industries, both on consulting and industry fronts.

More from our Insights

Woman working on a laptop in an office environment.
AI & GenAI

Claude Data Residency and Compliance Explained

Every enterprise conversation about Generative AI eventually reaches the same question. Where is our data actually processed and stored?

Read more
AI & GenAI

AI Ready in Pharma and Life Sciences: What the Research Reveals

Pharma and life sciences leaders agree that artificial intelligence (AI) is a strategic priority. But are they truly AI ready? With $236 billion in revenue at risk by 2030, many blockbuster drugs ...

Read more
Person working on a laptop with data visualizations overlaid, representing AI-driven analytics discussed in a podcast
AI & GenAI

Volatility to Value: Designing Intelligent Organizations in the AI Age

In an increasingly unpredictable business landscape, volatility is no longer an exception; it is the standard operating environment. Market conditions shift rapidly, customer preferences evolve ...

Read more
Go to Insights